{"id":16100,"date":"2013-01-15T02:30:00","date_gmt":"2013-01-15T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/fimmg-poca-informazione-su-generico-piu-facile-scelta-brand\/"},"modified":"2013-01-15T02:30:00","modified_gmt":"2013-01-15T01:30:00","slug":"fimmg-poca-informazione-su-generico-piu-facile-scelta-brand","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/fimmg-poca-informazione-su-generico-piu-facile-scelta-brand\/","title":{"rendered":"Fimmg: little information on generics, easier choice of brands"},"content":{"rendered":"

\"\"<\/font><\/span><\/p>\n

It is the lack of information on the part of generic manufacturers that does not allow the doctor to "deepen his knowledge of these drugs well". It is what is claimed by Giacomo Milillo<\/b>, secretary of Fimmg, commenting both the data on the sector's market share (17%), always lower than that of the USA (80%) and the European average (55%), and the distrust of doctors and patients revealed by two recent American researches. \u00abThe manufacturers of generic drugs don't give much information\u00bb clarifies Milillo \u00abthe doctor cannot therefore deepen the knowledge of these drugs and their side effects which can be different, because it is always necessary to remember that saying that they are equivalent to the one with non-brand it means that they are the same". And he adds: \u00abThe doctor needs to be fully aware of what he has prescribed, for this reason in the end it is easier for the choice to fall on drugs that he already knows\u00bb. Objections to which Giorgio Foresti<\/b>, president of Assogenerici replies by reiterating that \u00abif the pharmaceutical manufacturers of equivalent drugs want to continue selling products that cost 60% on average less than the branded ones, since they cannot sacrifice quality, they must necessarily give up investing in research, given that the molecules they use have already been discovered, and in scientific medical information\u00bb, and inviting doctors to consider the possibility of \u00abinforming yourself\u00bb. According to Foresti, the distrust of patients is justifiable by the introduction "a bit forced, justifying the choice only with economic savings, but not that of the doctor, indeed he must be the one to dispel any fear by immediately prescribing a generic drug where possible \u00bb. And he concludes: \u00abThe rule of double wording in the recipe, active ingredient plus possibly the name of the drug, recently introduced by Balduzzi seems right to me: it is a first step in educating citizens\u00bb.<\/p>\n

<\/font><\/span><\/p>\n

15 January 2013 \u2013 DoctoNews33<\/p>\n

<\/span><\/i><\/p>\n

 You see: http:\/\/www.federaisf.org\/Start\/HDefault.aspx?Newsid=7301<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"

È la poca informazione da parte dei produttori di generici che non permette al medico di «approfondire bene la conoscenza di questi farmaci». È quanto sostenuto da Giacomo Milillo, segretario della Fimmg commentando sia i dati sulla quota di mercato del comparto (17%), sempre inferiore a quella degli Usa (80%) e della media europea (55%), …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16100"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16100\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}